Lista de obras -

A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia

artículo científico publicado en 2005

A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma.

artículo científico publicado en 2008

A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts

artículo científico publicado en 2020

A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia.

artículo científico publicado en 2014

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3.

artículo científico publicado en 2016

Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: a prospective follow-up study

artículo científico publicado en 2014

Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.

artículo científico publicado en 2015

Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence

artículo científico publicado en 2015

An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.

artículo científico publicado en 2007

Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes

artículo científico publicado en 2015

Barrett's esophagus: cancer and molecular biology.

artículo científico

Barrett's esophagus: genetic and cell changes

artículo científico publicado en 2011

Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel

artículo científico publicado en 2014

Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.

artículo científico publicado en 2007

Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia.

artículo científico publicado en 2006

Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors

artículo científico publicado en 2016

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process

artículo científico publicado en 2012

Cytokeratin and CDX-2 expression in Barrett's esophagus

artículo científico publicado en 2008

Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.

artículo científico publicado en 2015

Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases

artículo científico publicado en 2011

Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus

artículo científico publicado en 2016

Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies

artículo científico publicado en 2015

Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population

artículo científico publicado en 2007

Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus

artículo científico publicado en 2005

Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection

artículo científico publicado en 2008

Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.

artículo científico publicado en 2017

Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract

artículo científico publicado en 2015

Genetic Abnormalities in Biliary Brush Samples for Distinguishing Cholangiocarcinoma from Benign Strictures in Primary Sclerosing Cholangitis

artículo científico publicado en 2016

Genetic and Epigenetic Abnormalities in Primary Sclerosing Cholangitis-associated Cholangiocarcinoma ⬇️

artículo científico publicado el 1 de julio de 2013

Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report

artículo científico publicado en 2018

Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model

artículo científico publicado en 2019

Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus

scientific article published on 26 December 2007

Increased phosphorylation on residue S795 of the retinoblastoma protein in esophageal adenocarcinoma

artículo científico publicado en 2015

Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus

artículo científico publicado en 2007

Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated

scientific article published on 11 May 2010

MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study

artículo científico publicado en 2014

Molecular pathogenesis of Barrett esophagus: current evidence

artículo científico

Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls.

artículo científico publicado en 2007

Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response.

artículo científico publicado en 2013

Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus

artículo científico publicado en 2007

Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis

artículo científico publicado en 2016

Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia

artículo científico publicado en 2016

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus ⬇️

artículo científico publicado en 2014

Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers.

artículo científico publicado en 2014

Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports

artículo científico publicado en 2008

Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine.

artículo científico publicado en 2009

Reproducibility of Protein Identification of Selected Cell Types in Barrett’s Esophagus Analyzed by Combining Laser-Capture Microdissection and Mass Spectrometry ⬇️

artículo científico publicado el 3 de diciembre de 2010

Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study

artículo científico publicado en 2006

Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.

artículo científico publicado en 2014

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel

artículo científico publicado en 2017

The dynamics of HER2 status in esophageal adenocarcinoma.

artículo científico publicado en 2018

Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery.

artículo científico publicado en 2010

Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus

scientific article published on 07 May 2008

Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.

artículo científico publicado en 2015

Lista de obras de

A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia

A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma.

A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts

A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia.

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3.

Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: a prospective follow-up study

Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.

Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence

An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.

Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes

Barrett's esophagus: cancer and molecular biology.

Barrett's esophagus: genetic and cell changes

Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel

Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.

Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia.

Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process

Cytokeratin and CDX-2 expression in Barrett's esophagus

Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.

Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases

Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus

Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies

Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population

Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus

Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection

Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.

Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract

Genetic Abnormalities in Biliary Brush Samples for Distinguishing Cholangiocarcinoma from Benign Strictures in Primary Sclerosing Cholangitis

Genetic and Epigenetic Abnormalities in Primary Sclerosing Cholangitis-associated Cholangiocarcinoma ⬇️

Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report

Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model

Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus

Increased phosphorylation on residue S795 of the retinoblastoma protein in esophageal adenocarcinoma

Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus

Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated

MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study

Molecular pathogenesis of Barrett esophagus: current evidence

Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls.

Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response.

Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus

Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis

Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus ⬇️

Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers.

Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports

Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine.

Reproducibility of Protein Identification of Selected Cell Types in Barrett’s Esophagus Analyzed by Combining Laser-Capture Microdissection and Mass Spectrometry ⬇️

Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study

Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel

The dynamics of HER2 status in esophageal adenocarcinoma.

Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery.

Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus

Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.